<DOC>
	<DOCNO>NCT00925418</DOCNO>
	<brief_summary>Taxotere® induce nail change like dyschromia , hematoma , line Beau-Reil ( sign stop epithelial proliferation ) , abscess , pain . In context , randomize , monocentric phase III trial evaluate cryotherapy , use frozen glove , prevention nail toxicity induce Taxotere® patient treat breast prostate cancer . Primary objective : Demonstrate reduction nail toxicity use frozen glove chemotherapy Taxotere® . Secondary objective : Analysis time protection onycholysis Estimation efficiency cryotherapy , impact quality life Tolerance compliance frozen glove</brief_summary>
	<brief_title>Evaluation Cryotherapy Prevention Nails Toxicity Induced Taxotere® Breast Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Nail Diseases</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<criteria>Patients hormonoresistant breast cancer metastatic prostate cancer treat chemotherapy Taxotere® . Patients age 18 old Nail toxicity &lt; grade 2 ( CTCAE version 3.0 ) Informed patient signed consent History treatment taxane Raynaud syndrome Distal metastasis superior extremity Nail diseases Distal arteriopathy Cold intolerance Peripheral neuropathy &gt; =2 Pregnancy , breast feeding Unable give inform consent Unable medical followup social , geographical , family psychological reason</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Neoplasm</keyword>
	<keyword>breast Neoplasm</keyword>
	<keyword>docetaxel</keyword>
	<keyword>Glove</keyword>
</DOC>